Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplastic Pathology”

4,798 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,798 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Very early researchStudy completedNCT04130152
What this trial is testing

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 22
Early research (Phase 1)UnknownNCT05302843
What this trial is testing

BPI-28592 in Subjects With Advanced Solid Tumors

Who this might be right for
Metastasis, Neoplasm
Betta Pharmaceuticals Co., Ltd. 40
Not applicableStudy completedNCT02801409
What this trial is testing

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

Who this might be right for
Lung CancerThoracic SurgeryAnesthesia, Epidural+2 more
Peking University First Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableUnknownNCT00689364
What this trial is testing

Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ministry of Science and Technology of the People´s Republic of China 480
Testing effectiveness (Phase 2)Study completedNCT00053287
What this trial is testing

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 42
Early research (Phase 1)Ended earlyNCT03742349
What this trial is testing

Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)UnknownNCT01196455
What this trial is testing

Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasis
Croatian Cooperative Group for Clinical Research in Oncology 39
Not applicableUnknownNCT04547634
What this trial is testing

Telerehabilitation in Oncology Patients

Who this might be right for
Cancer MetastaticCancerSurvivorship
University of Malaga 30
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Early research (Phase 1)Study completedNCT01919398
What this trial is testing

LY2940680 in Japanese Participants With Advanced Cancers

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 19
Testing effectiveness (Phase 2)Study completedNCT00886132
What this trial is testing

Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Who this might be right for
Adenoid Cystic CarcinomaSalivary Gland Cancer
University Health Network, Toronto 14
Large-scale testing (Phase 3)Temporarily pausedNCT05351294
What this trial is testing

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

Who this might be right for
Radiation TherapyMetastatic Cancer
Rutgers, The State University of New Jersey 156
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT01009177
What this trial is testing

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Who this might be right for
Melanoma
Actelion 80
Testing effectiveness (Phase 2)Looking for participantsNCT07176312
What this trial is testing

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Who this might be right for
Gastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Testing effectiveness (Phase 2)Study completedNCT00271687
What this trial is testing

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisPalliative Care
AHS Cancer Control Alberta 30
Early research (Phase 1)Study completedNCT00327652
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases

Who this might be right for
Neoplasm MetastasisLiver NeoplasmsCarcinoma
Anza Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT01309633
What this trial is testing

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 80
Load More Results